Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential
Author:
Affiliation:
1. Faculdade de Ciências; Universidade de Lisboa; Ed. C8, Campo Grande 1749-016 Lisbon Portugal
2. CEDOC Chronic Diseases; Nova Medical School; Rua Câmara Pestana n 6, 6-A, Ed. CEDOC II 1150-082 Lisbon Portugal
Funder
Fundação para a Ciência e a Tecnologia
European Union 7th Framework Programme
Publisher
Wiley
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Reference494 articles.
1. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo;Farris;Proc Natl Acad Sci USA,2003
2. Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance;Abdul-Hay;PLoS One,2011
3. Seminars in medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus-A genetically programmed failure of the beta cell to compensate for insulin resistance;Polonsky;N Engl J Med,1996
4. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes;Kotronen;Gastroenterology,2008
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice;Experimental and Clinical Endocrinology & Diabetes;2024-04-03
2. Re-Engineering Therapeutic Anti-Aβ Monoclonal Antibody to Target Amyloid Light Chain;International Journal of Molecular Sciences;2024-01-27
3. Unravelling of molecular biomarkers in synaptic plasticity of Alzheimer’s disease: Critical role of the restoration of neuronal circuits;Ageing Research Reviews;2023-11
4. Alzheimer's disease from a diabetic brain: Exploring the molecular process to determine the potential therapy target from marine sources;Pharmacy Education;2023-10-10
5. Crosstalk between Alzheimer’s disease and diabetes: a focus on anti-diabetic drugs;Metabolic Brain Disease;2023-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3